Impact of the expanded label for elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with no F508del variant in the United States.
Elizabeth A CromwellJosh S OstrengaDon B SandersWayne MorganCarlo CastellaniRhonda SzczesniakPierre Regis BurgelPublished in: The European respiratory journal (2024)
Keyphrases